naion semaglutide news Can Semaglutides (Ozempic) Cause Blindness? A recent study hints at a potential link between use and an increased risk of a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION ) Semaglutide linked to increased risk

Tirzepatide is a dual GIP and GLP-1 receptor agonist, while semaglutide is solely a GLP-1 receptor agonist

First non-peptide oral GLP-1 for chronic weight management No injections required No fasting or food restrictions Demonstrated ~12.4% weight loss in Phase 3 trials This innovation has the potential to improve patient acceptance and adherence, making evidence-based obesity treatment more accessible than ever

More treatment options still need to be explored

T., Garcia, M

A prolonged, untreated deficiency can cause nerve damage that may become permanent

Yes, typically within three to six months after opening